Larvol Delta - To-Evaluate-the-Phase-III-Clinical-Trial-of-TQH2722-Injection-in-the-Treatment-of-Moderate-to-Severe-Atopic-Dermatitis

TQH2722 - Sino Biopharm, Biosion

http://clinicaltrials.gov/ct2/show/NCT06552520

Apr 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next